Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01- Clinical Trial Not Allowed)

Funding Opportunity RFA-DA-18-023 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement [FOA] is to support research that will define and validate a set(s) of molecular biomarkers and/or bio-signatures indicating the degree of loss of functional reserve, or of resilience of the host defense mechanisms, at different phases of HIV-1 pathogenesis in individuals with substance use disorders (SUDs).
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding